This inventor holds 5 USPTO granted patents. Top assignee: Ascent Pharmaceuticals, Inc.. Active years: 1996-1997.
Company Filing History:
Years Active: 1996-1997
Title: Mumtaz Ahmed: Innovator in the Field of Hypersensitivity Treatment
Introduction
Mumtaz Ahmed, an accomplished inventor based in Westford, MA, has made significant contributions to the field of medical treatment, particularly in addressing hypersensitivity reactions. With a total of five patents to her name, Ahmed stands out as a prominent figure in pharmaceutical innovation.
Latest Patents
Among her latest inventions is a groundbreaking pharmaceutical composition designed for the prevention and treatment of cutaneous Type I hypersensitivity reactions in humans. The composition features a chromone compound, which can exist as a pharmacologically acceptable salt, ester, or amide, and is intended to be dissolved or dispersed in a suitable carrier. The unique process involves the topical administration of a therapeutically effective amount of the composition to the affected areas. This innovation not only aims to prevent reactions by being applied to susceptible skin areas but also offers treatment options at the reaction site as needed.
Career Highlights
Mumtaz Ahmed has developed a reputation for her research and development work at Ascent Pharmaceuticals, Inc., where she focuses on creating effective therapeutic solutions. Her innovative spirit and dedication to improving patient outcomes have been instrumental in her accomplishments.
Collaborations
Throughout her career, Ahmed has collaborated with talented colleagues, including Emmett Clemente and Robert W Mendes. These partnerships have contributed to her innovative endeavors and facilitated the growth of their collective expertise in the pharmaceutical industry.
Conclusion
Mumtaz Ahmed's contributions to the field of pharmaceuticals, especially in the treatment of hypersensitivity reactions, underscore her talent as an inventor. With her continually evolving portfolio of patents, she is poised to make even more profound impacts in the healthcare sector in the future.